Mannatech MTEX Q3 2023 Earnings Narrow Profit as Revenue Challenges Persist Everest Group EG Q1 2026 Earnings Strong EPS Beat Amid Resilient Underwriting Results LMND Q1 2026 Earnings Narrowing Losses Beat Expectations as Underwriting Improves Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development WAFDP Q1 2026 Earnings Earnings Beat Estimates Amid Steady Performance ORLY Q1 2026 Earnings EPS Beat Provides Mixed Sentiment Amid Broader Market Pullback